Industries > Pharma > The Global Respiratory Inhalers Market 2020-2030

The Global Respiratory Inhalers Market 2020-2030

Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others

PUBLISHED: 28 January 2020
PAGES: 168
PRODUCT CODE: PHA0669
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0669 Categories: , Tags: , , ,

Visiongain estimates that the global respiratory inhalers market reached $32.6bn in 2019 and will grow at a CAGR of 3.9% in the first half of the forecast period. In 2019, the Dry Powder Inhalers submarket held 56% of the global respiratory inhalers market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 168-page report you will receive 121 charts and 2 interviews– all unavailable elsewhere.

The 168-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Respiratory Inhalers Market from 2020-2030

• Forecast of the Global Respiratory Inhalers market by Type of Product:
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs
• Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers

• Forecast of the Global Respiratory Inhalers market by Indication:
• Asthma
• COPD
• Other Respiratory Diseases

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Russia
• Brazil
• Mexico
• Canada

The Global Respiratory Inhalers Market 2020-2030

• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici S.p.A.
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Teva

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the Porter’s Five Forces Analysis of the respiratory inhalers market.

• Key questions answered by this report:
• How is the Respiratory Inhalers market evolving?
• What are the drivers and restraints for the growth of the Respiratory Inhalers market?
• What are the market shares of each segment of the overall Respiratory Inhalers market in 2020?
• How will each Respiratory Inhalers submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each Respiratory Inhalers submarket develop from 2020 to 2030?
• What will be the main driver for the overall market from 2020 to 2030?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.

Buy our report today The Global Respiratory Inhalers Market 2020-2030: Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for The Global Respiratory Inhalers Market 2020-2030


Download sample pages

Complete the form below to download your free sample pages for The Global Respiratory Inhalers Market 2020-2030


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories